methylformamide has been researched along with Rectal Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, E; Geller, N; Hollander, P; Kemeny, N; Tauer, K | 1 |
| Abrams, J; Eisenberger, M; Kaplan, RS; Tchekmedyian, NS; Van Echo, D | 1 |
| Klijn, JG; Planting, AS; Stoter, G; Verweij, J | 1 |
| Eisenhauer, EA; Kerr, I; Quirt, I; Weinerman, BH | 1 |
1 trial(s) available for methylformamide and Rectal Neoplasms
| Article | Year |
|---|---|
Phase II trial of N-methylformamide in patients with advanced colorectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Colonic Neoplasms; Drug Evaluation; Female; Formamides; Humans; Male; Middle Aged; Rectal Neoplasms; Sepsis | 1986 |
3 other study(ies) available for methylformamide and Rectal Neoplasms
| Article | Year |
|---|---|
Phase II study of N-methylformamide in patients with advanced colorectal cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Female; Formamides; Humans; Male; Middle Aged; Rectal Neoplasms | 1987 |
Phase II study on oral N-methylformamide in metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Carcinoma; Colonic Neoplasms; Drug Evaluation; Female; Formamides; Humans; Male; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms | 1987 |
Toxicity of oral N-methylformamide in three phase II trials: a report from the National Cancer Institute of Canada Clinical Trials Group.
Topics: Alkaline Phosphatase; Antineoplastic Agents; Aspartate Aminotransferases; Bilirubin; Canada; Chemical and Drug Induced Liver Injury; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Formamides; Glioma; Humans; Male; Melanoma; Nausea; Rectal Neoplasms | 1986 |